Myeloid calcineurin promotes NFAT-dependent IL-6 transcription, which then acts on tumour cells and supports epithelial B7H3 and B7H4 expression in a STAT3-dependent manner [82]. The gene discussed is VTCN1; the disease is neoplasm.